Apofasl: a novel immunotherapeutic for T1D
Ended Block Grant Awarded
- Award ID
- R43DK079394
- Recipient
-
Apovax, Inc. UEI LT59MH2NTJP1
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $421,676
Award facts
- Assistance listing
- 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research
- Completion date
- Place of performance
- Kentucky, USA
Award details come from USAspending.gov.
Quick answers
Who received award R43DK079394?
R43DK079394 was awarded to Apovax, Inc. by National Institutes of Health (Department of Health and Human Services) on August 6, 2007.
How much is award R43DK079394 worth?
$421,676 has been obligated on R43DK079394.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award